Guardant Health Inc.
Organization details
- Legal name
- Guardant Health Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Palo Alto
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001576280
- EIN
- 45-4139254
Board of directors
-
Alex M. Azar II · DirectorSince 2025
-
AmirAli Talasaz · Director · Co-Chief Executive OfficerSince 2023
-
Helmy Eltoukhy · Director · Co-Chief Executive OfficerSince 2023
- Since 2023
-
Kevin R. Sayer · DirectorSince 2026
-
Medina Manuel Hidalgo · DirectorSince 2024
-
Meghan Joyce V · DirectorSince 2023
-
Musa Tariq · DirectorSince 2023
-
Myrtle S. Potter · DirectorSince 2023
-
Roberto Mignone · DirectorSince 2024
-
Samir Kaul · DirectorSince 2023
-
Steve E. Krognes · DirectorSince 2023
-
Vijaya Gadde · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
65.0%
Board connections
8 of this board's directors also sit on 15 other boards. 12 are in the same sector.
-
BioMarin Pharmaceutical Inc. Same sectorvia Ian T. Clark
-
Bristol-Myers Squibb Company Same sectorvia Medina Manuel Hidalgo
-
Corvus Pharmaceuticals Inc. Same sectorvia Ian T. Clark
-
Denali Therapeutics Inc. Same sectorvia Steve E. Krognes
-
DexCom Inc. Same sectorvia Kevin R. Sayer
-
Ginkgo Bioworks Holdings Inc. Same sectorvia Myrtle S. Potter
- via Ian T. Clark
-
Kyverna Therapeutics Inc. Same sectorvia Ian T. Clark
-
Olema Pharmaceuticals Inc. Same sectorvia Ian T. Clark
- via Vijaya Gadde
-
Pliant Therapeutics Inc. Same sectorvia Steve E. Krognes
-
Takeda Pharmaceutical Company Limited Same sectorvia Ian T. Clark
-
Tectonic Therapeutic Inc. Same sectorvia Ian T. Clark
-
Teva Pharmaceutical Industries Limited Same sectorvia Roberto Mignone
- via Meghan Joyce V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $78,456
- 1 purchase by 1 insider
- Sold, last 12 months
- $172,912,480
- 140 sales by 15 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2026 | Alex M. Azar II Director | Option exercise | +138 | — | — |
| Oct 21, 2026 | Roberto Mignone Director | Option exercise | +264 | — | — |
| Oct 17, 2026 | Medina Manuel Hidalgo Director | Option exercise | +232 | — | — |
| Oct 16, 2026 | Musa Tariq Director | Open-market sale | −116 | $165.88 | $19,242 |
| Oct 15, 2026 | Musa Tariq Director | Option exercise | +250 | — | — |
| Oct 12, 2026 | Alex M. Azar II Director | Option exercise | +137 | — | — |
| Oct 1, 2026 | Bell Michael Brian Officer (Chief Financial Officer) | Option exercise | +2,085 | — | — |
| Oct 1, 2026 | Chudova Darya Officer (Chief Technology Officer) | Option exercise | +1,340 | — | — |
| Oct 1, 2026 | Freeman Chris Officer (Chief Commercial Officer) | Option exercise | +1,929 | — | — |
| Oct 1, 2026 | Monroe Terilyn J. Officer (Chief People Officer) | Option exercise | +2,659 | — | — |
| Oct 1, 2026 | Saia John G. Officer (Chief Legal Officer) | Option exercise | +974 | — | — |
| Oct 1, 2026 | Kalia Kumud Officer (Chief Information Officer) | Option exercise | +1,607 | — | — |
| Oct 1, 2026 | Bell Michael Brian Officer (Chief Financial Officer) | Option exercise | +3,324 | — | — |
| Oct 1, 2026 | Chudova Darya Officer (Chief Technology Officer) | Option exercise | +1,668 | — | — |
| Oct 1, 2026 | Freeman Chris Officer (Chief Commercial Officer) | Option exercise | +1,668 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Guardant Health Inc.
Who is the CEO of Guardant Health Inc.?
Helmy Eltoukhy is Guardant Health Inc.'s Co-Chief Executive Officer.
How many directors are on Guardant Health Inc.'s board?
Guardant Health Inc.'s board has 13 directors: Alex M. Azar II, AmirAli Talasaz, Helmy Eltoukhy, Ian T. Clark, Kevin R. Sayer, Medina Manuel Hidalgo, Meghan Joyce V, Musa Tariq, Myrtle S. Potter, Roberto Mignone and 3 others.
Are Guardant Health Inc. insiders buying or selling shares?
Over the last 12 months, Guardant Health Inc. insiders bought $78,456 of shares in 1 purchase and sold $172.9 million of shares in 140 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="guardant-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.